Horizon Therapeutics (HZNP) Misses Q2 EPS by 26c
Get Alerts HZNP Hot Sheet
Join SI Premium – FREE
Horizon Therapeutics (NASDAQ: HZNP) reported Q2 EPS of $1.07, $0.26 worse than the analyst estimate of $1.33. Revenue for the quarter came in at $876.4 million versus the consensus estimate of $936.11 million.
GUIDANCE:
Horizon Therapeutics sees FY2022 revenue of $3.53-3.6 billion, versus the consensus of $3.96 billion.
For earnings history and earnings-related data on Horizon Therapeutics (HZNP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- O'Reilly Automotive (ORLY) Misses Q1 EPS by 7c, Offers Guidance
- Amerant Bancorp Inc. (AMTB) Misses Q1 EPS by 5c
- WM (WM) Tops Q1 EPS by 25c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!